QNR
TW EN

scroll

Go Top

丘以思生技顧問有限公司

Clinipace Worldwide

Highlights

Clinipace Worldwide is a digital CRO (dCRO) that leverages clinical expertise with proprietary technology to optimize timeline performance and contain costs. We take pride in our expertise in the operational, regulatory, and scientific aspects of your clinical trial. From managing your entire development program to conducting an individual clinical trial, our experts bring extensive therapeutic and local experience in building a well-defined clinical plan to maximize your success.

In August 2015, Clinipace was named to Inc. Magazine’s annual Inc. 500 for the sixth consecutive year. This prestigious list is a compilation of the fastest-growing privately held companies in the country, recognizing their success and potential for the future.

In November 2014, Clinipace was named to the Top 50 of Triangle Business Journal’s Fast 50 Award for the fifth consecutive year.

In 2013, Clinipace was ranked #36 in FORBES’ list of America’s 100 Most Promising Companies.

Services

  • 01

    Clinical Development & Project Management

  • 02

    Regulatory & Strategic Development Consulting

  • 03

    eClinical Platform

  • 04

    Data Management & Biostatistics

  • 05

    Medical Affairs

Back to list

Introduction

About Us History

Taiwan Spotlight

Health Overview Clinical Trial Focus International Accreditations
Clinical Trial Centers TCTC c-IRB
Resources News e-LEARNING Contact Us
All Contents Copyright 2019 Center for Drug Evaluation (CDE),Taiwan/ This website is operated by Center for Drug Evaluation (CDE), Taiwan